Akèy › Skleroderm Difize › North Carolina › Durham
Etid klinik pou Skleroderm Difize nan Durham, NC
6 etid pou Skleroderm Difize ap chèche patisipan nan sit nan ak bò kote Durham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Ap rekriteFaz 1
- Duke University Medical Center, Durham
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Ap rekriteFaz 1
- University of North Carolina TraCS Institute - CTRC, Chapel Hill · 10 mi lwen
Platform Clinical Study for Conquering Scleroderma
Ap rekriteFaz 2
- Duke University Medical Center, Durham
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Ap rekriteFaz 2/3
- Duke University, Durham
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Ap rekriteFaz 1
- Duke University, Durham
Maternal Autoimmune Disease Research Alliance (MADRA) Registry
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Duke University, Durham
Etid Skleroderm Difize nan lòt vil
- New York City, NY8 etid
- Chicago, IL7 etid
- Ann Arbor, MI7 etid
- Los Angeles, CA6 etid
- Baltimore, MD5 etid
- Houston, TX5 etid
- Boston, MA5 etid
- Pittsburgh, PA4 etid
- Kansas City, KS4 etid
- New Orleans, LA4 etid
- Philadelphia, PA4 etid
- Cedar Rapids, IA3 etid
Lòt etid nan Durham
- Kansè nan tete63 etid
- Kansè (tout kalite)58 etid
- Kansè Poumon ki pa ti selil39 etid
- Myelom Miltip37 etid
- Kansè Metastatik33 etid
- Leksemi mieloïd egi33 etid
- Kansè pwostat32 etid
- Kansè poumon32 etid
- Kansè kolorektal28 etid
- Lukemi lenfositè kwonik27 etid
- Kansè ovè27 etid
- Ensifizyans kadyak26 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.